BRPI0918873A2 - pollissulfatos de ciclodextrina carboxialquilados úteis como medicamentos. - Google Patents

pollissulfatos de ciclodextrina carboxialquilados úteis como medicamentos.

Info

Publication number
BRPI0918873A2
BRPI0918873A2 BRPI0918873A BRPI0918873A BRPI0918873A2 BR PI0918873 A2 BRPI0918873 A2 BR PI0918873A2 BR PI0918873 A BRPI0918873 A BR PI0918873A BR PI0918873 A BRPI0918873 A BR PI0918873A BR PI0918873 A2 BRPI0918873 A2 BR PI0918873A2
Authority
BR
Brazil
Prior art keywords
pollisulfates
carboxyalkylated
cyclodextrin
medicaments
useful
Prior art date
Application number
BRPI0918873A
Other languages
English (en)
Inventor
August Lodewijk Verbruggen
Dirk Elewaut
Original Assignee
Arcarios B V
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Arcarios B V filed Critical Arcarios B V
Publication of BRPI0918873A2 publication Critical patent/BRPI0918873A2/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/0006—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
    • C08B37/0009—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid alpha-D-Glucans, e.g. polydextrose, alternan, glycogen; (alpha-1,4)(alpha-1,6)-D-Glucans; (alpha-1,3)(alpha-1,4)-D-Glucans, e.g. isolichenan or nigeran; (alpha-1,4)-D-Glucans; (alpha-1,3)-D-Glucans, e.g. pseudonigeran; Derivatives thereof
    • C08B37/0012—Cyclodextrin [CD], e.g. cycle with 6 units (alpha), with 7 units (beta) and with 8 units (gamma), large-ring cyclodextrin or cycloamylose with 9 units or more; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/724—Cyclodextrins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Diabetes (AREA)
  • Biochemistry (AREA)
  • Hematology (AREA)
  • Polymers & Plastics (AREA)
  • Virology (AREA)
  • Materials Engineering (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Rheumatology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pain & Pain Management (AREA)
  • AIDS & HIV (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
BRPI0918873A 2008-09-22 2009-09-22 pollissulfatos de ciclodextrina carboxialquilados úteis como medicamentos. BRPI0918873A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP08164818 2008-09-22
PCT/EP2009/062277 WO2010031876A1 (en) 2008-09-22 2009-09-22 Carboxyethylated cyclodextrin polysulfates useful as medicaments

Publications (1)

Publication Number Publication Date
BRPI0918873A2 true BRPI0918873A2 (pt) 2015-12-01

Family

ID=40342087

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0918873A BRPI0918873A2 (pt) 2008-09-22 2009-09-22 pollissulfatos de ciclodextrina carboxialquilados úteis como medicamentos.

Country Status (9)

Country Link
US (1) US8466278B2 (pt)
EP (1) EP2331581A1 (pt)
JP (1) JP5508421B2 (pt)
KR (1) KR20110067130A (pt)
CN (1) CN102300880B (pt)
BR (1) BRPI0918873A2 (pt)
CA (1) CA2738018A1 (pt)
EA (1) EA018959B1 (pt)
WO (1) WO2010031876A1 (pt)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6228137B2 (ja) * 2012-01-30 2017-11-08 バクスアルタ ゲーエムベーハー 非抗凝固性の硫酸化またはスルホン酸化多糖
ITMI20132116A1 (it) 2013-12-18 2015-06-19 Apharm Srl Associazione di glicosamminoglicani e ciclodestrine
DK3448395T3 (da) * 2016-04-29 2020-06-02 Alveron Pharma B V Cyclodextriner som prokoagulanter
JP2023502399A (ja) * 2019-11-18 2023-01-24 サイデックス・ファーマシューティカルズ・インコーポレイテッド アルキル化シクロデキストリン組成物並びにこれを製造及び使用する方法
CN113528488B (zh) * 2021-08-17 2022-09-27 南昌大学 一种树脂搅拌吸附制备高质量玻璃酸酶粗品的方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE68910113T2 (de) * 1988-01-19 1994-03-17 Childrens Hospital Corp Wachstuminhibierendes mittel und dessen verwendung.
US5760015A (en) 1988-01-19 1998-06-02 The Trustees Of The University Of Pennsylvania Cyclodextrin compounds and methods of making and use thereof
JP2556236B2 (ja) * 1991-08-29 1996-11-20 田辺製薬株式会社 β−シクロデキストリン誘導体のポリ硫酸エステル及びその製法
EP0612249A4 (en) * 1991-11-11 1995-11-08 Univ Pennsylvania Methods of inhibiting restenosis.
CN1241576C (zh) * 1999-08-13 2006-02-15 阿克佐诺贝尔公司 化学螯合剂用于制备逆转临床使用的神经肌肉传导阻滞剂药物诱发的神经肌肉传导阻滞的药物的用途
DE20023640U1 (de) 1999-10-06 2005-06-23 Tigenix N.V. Isolierung von Vorläuferzellen und deren Verwendung zum Wiederaufbau von Bindegewebe
FR2811572B1 (fr) 2000-07-17 2003-04-18 Adir Utilisation de cyclodextrines polysulfatees pour le traitement de l'arthrose
DK1653994T3 (da) 2003-08-12 2010-03-15 Tigenix Nv Anvendelse af CXCL6 chemokin i forebyggelsen eller gendannelse af bruskdefekter

Also Published As

Publication number Publication date
US8466278B2 (en) 2013-06-18
EP2331581A1 (en) 2011-06-15
US20110172182A1 (en) 2011-07-14
CN102300880B (zh) 2013-06-19
EA018959B1 (ru) 2013-12-30
CA2738018A1 (en) 2010-03-25
KR20110067130A (ko) 2011-06-21
WO2010031876A1 (en) 2010-03-25
JP5508421B2 (ja) 2014-05-28
EA201170369A1 (ru) 2011-10-31
JP2012503059A (ja) 2012-02-02
CN102300880A (zh) 2011-12-28

Similar Documents

Publication Publication Date Title
BRPI0919295A2 (pt) 1h-benzimidazol-5-carboxamidas como agentes anti-inflamatórios.
NO2021006I1 (no) Quofenix, delafloksacin
BRPI0906611A2 (pt) Produtos implantáveis compreendendo nanopartículas.
BRPI0920428A2 (pt) inalador.
BRPI0918430A2 (pt) 4-fenil-1h-pirazóis inseticidas.
BRPI0923912A2 (pt) aparelho de cateter.
BRPI1011965A2 (pt) estrutura de entressola.
BRPI1007310A2 (pt) Compostos inseticidas.
BRPI1008939A2 (pt) 2-mercaptoquinolina-3-carboxamidas substituídas como moduladores de kncq2/3.
FR2964987B1 (fr) Souffleur electroportatif.
BRPI0922391A2 (pt) pneumático.
BRPI1016190A2 (pt) compostos farmacêuticos.
BRPI0923418A2 (pt) pneumático.
IT1400534B1 (it) Veicolo di piccole dimensioni.
BRPI0917446A2 (pt) derivados de acilaminobenzamida.
IT1396487B1 (it) Convogliatore.
BRPI1011460A2 (pt) Composição desinfetante.
IT1397667B1 (it) Rotismo.
BRPI1016192A2 (pt) derivados de soxazol.
DK2442870T3 (da) Pyrazinooxazepin-derivater.
BRPI1013966A2 (pt) microensaio de esterilidade rápida.
BRPI1013799A2 (pt) eletrodos de desfibrilação.
BRPI1011794A2 (pt) compartimento.
BRPI0923387A2 (pt) pneumático.
BRPI0918873A2 (pt) pollissulfatos de ciclodextrina carboxialquilados úteis como medicamentos.

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 7A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2384 DE 13-09-2016 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.